Grown Rogue International (GRUSF) Capital Leases (2017 - 2026)
Grown Rogue International (GRUSF) posted quarterly Capital Leases of $51359.0 for Q1 2026, down 24.23% quarter-over-quarter from $67782.0 in Q4 2025.
Grown Rogue International (GRUSF) Capital Leases (2017 - 2026) Analysis & Trends
Grown Rogue International's Capital Leases history runs 6 years deep, the most recent figure standing at $51359.0 for Q1 2026.
- In Q1 2026, Capital Leases changed N/A year-over-year to $51359.0; the TTM figure through Mar 2026 stood at $51359.0 (changed N/A YoY), while the FY2025 annual figure was $67782.0, changed N/A from the prior year.
- Capital Leases for Q1 2026 stood at $51359.0, down from $67782.0 in the prior quarter.
- The five-year high for Capital Leases was $67782.0 in Q4 2025, with the low at $51359.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Grown Rogue International | 109.32 Mn | 97.78 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40,565.00 |
| Mar 31, 2026 | 51,359.00 |
| Dec 31, 2025 | 67,782.00 |
| Jul 31, 2020 | 72,908.00 |
| Apr 30, 2020 | 95,087.00 |
| Jan 31, 2020 | 104,130.00 |
| Oct 31, 2019 | 129,876.00 |
| Jul 31, 2019 | 138,162.00 |
| Apr 30, 2019 | 136,767.00 |
| Jan 31, 2019 | 103,371.00 |
| Oct 31, 2018 | 99,134.00 |
| Apr 30, 2018 | 149,321.00 |
| Oct 31, 2017 | 82,810.00 |